KALARIS THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number
KALARIS THERAPEUTICS, INC. (KLRS) reported Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number of 28.95 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber · last filed 2025-03-07
- KALARIS THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2024-12-31 was -635.29K shares.
- KALARIS THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2024-09-30 was 0.00 shares.
- KALARIS THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2024-06-30 was 63.13K shares.
- KALARIS THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2024-03-31 was 601.12K shares.
- KALARIS THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, accelerated vesting, number for fiscal 2024 was 28.95K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 12 month |
|---|---|---|---|---|
| 2024-12-31 | -635.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -635.29K shares derived: sum of 2 quarters · filed 2025-03-07 | -572.16K shares derived: sum of 3 quarters · filed 2025-03-07 | 28.95K shares 10-K · filed 2025-03-07 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-12 | 63.13K shares derived: sum of 2 quarters · filed 2024-11-12 | 664.25K shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 63.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 664.25K shares 10-Q · filed 2024-08-09 | ||
| 2024-03-31 | 601.12K shares 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |